Jaipur: Backing the clinical trial of Patanjali's Coronil, Rajasthan NIMS Chairman Dr BS Tomar on Friday said that Ayush Ministry granted permission to Patanjali for the trials. Tomar said that Government issued a gazette on May 22 saying that hospitals or allopathy units should proceed further for developing a vaccine for Covid-19.
"It was only after the govt granted permission that we approached Clinical Trials Registry-India(CTRI) which has been set up by Indian Council of Medical Research. Our permission number is CTRI/2020/05/025273. We were given permission for clinical trials for these prescribed medicines," he added.
Earlier, Rajasthan's Health Department had served a notice to NIMS hospital here seeking an explanation on conducting trials of Patanjali Ayurved's drug Coronil on coronavirus patients.
"We served notice to the hospital on Wednesday evening seeking explanation in three days. The hospital did not inform the state government nor sought permission," Chief Medical and Health Officer, Jaipur, Dr Narottam Sharma had said.
READ: Followed all procedures to manufacture medicine, didn't advertise it: Acharya Balkrishna
Acharya Balkrishna, Chief Executive Officer (CEO) of Patanjali, had earlier mentioned that all procedures were followed to manufacture the medicine, Coronil, and they have not done anything wrong while obtaining the licence.
"We have followed all procedures to manufacture the medicine (Coronil). We applied for the licence based on classical evidence of the compounds used in the medicine. We worked on the compounds and put out the results of the clinical trial before people," Acharya Balkrishna had said.
This comes after MoS for the Union Ayush Minister Shripad Naik said that Patanjali Ayurved should not have advertised its newly-launched ayurvedic drugs for COVID-19 before getting final approvals. (With input from agencies)
Read: Notice sent to Jaipur hospital for conducting trials of Patanjali drug on COVID-19 patients
